Information  X 
Enter a valid email address

Duke Royalty Limited (DUKE)

  Print      Mail a friend

Thursday 30 August, 2018

Duke Royalty Limited

New Royalty Agreement

RNS Number : 1841Z
Duke Royalty Limited
30 August 2018
 

30 August 2018

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

New Royalty Agreement with a Canadian Healthcare Organisation

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has entered into a £10 million royalty financing agreement (the "Financing") with InterHealth Canada Holding Corp ("ICHC").

 

ICHC is the wholly owned subsidiary of a 24-year-old Canadian-based organisation InterHealth Canada Limited ("InterHealth Canada") that specialises in the development, commissioning and management of healthcare facilities in various countries around the world. 

 

Highlights

·     This is the largest partner that Duke has funded to date

·    As Duke's fifth Royalty Partner, this transaction broadens Duke's revenue base and increases portfolio diversification, thereby reducing risk for investors

·     Further validates royalty finance as a preferable source of finance for well established, profitable businesses in Europe and abroad

·     This is the first deal to be completed in healthcare services, one of Duke's preferred and target sectors due to the reliable and recurring nature of revenues

·    Initial cash-on-cash yield of more than 13 per cent. per annum via monthly payments immediately payable post closing of the investment

·     30 year secured financing - distributions to be adjusted annually to reflect InterHealth Canada's consolidated revenue growth

 

Neil Johnson, CEO of Duke Royalty, said:

"I am delighted to announce this transaction with ICHC. With its exciting future growth plans and its long-term profitable operating history, ICHC represents an ideal long-term partner for Duke. Importantly, ICHC is the largest company with which Duke has transacted to date and, given that it represents our first investment in the healthcare services sector, we are pleased to have further diversified and de-risked the existing Duke portfolio."

 

New Royalty Partner

ICHC is a leading healthcare organization specialising in the development, commissioning and management of healthcare facilities and services using a public-private partnership model. Its core business is to export Canada's Healthcare intellectual and management expertise to other countries.

 

Established in 1994, InterHealth Canada has employed over 5,000 professionals worldwide and has provided healthcare to a combined population of over 20 million people. InterHealth Canada is committed to delivering internationally accredited healthcare management services with an emphasis on investment returns.  The head office is located in Toronto, Canada, with regional offices in Riyadh, London, Providenciales, Grand Turks, Warsaw and Dubai.

 

About the Financing

Duke has committed to provide ICHC with £10 million upon closing, with the ability to increase this investment by a further US$5 million on the agreement of both parties within a period of 150 days post closing.  

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a secured loan and Duke will be entitled to monthly distributions (the "Distribution") beginning in September 2018. On an annual basis, based on the £10 million initial investment amount, the Year 1 annual distribution is expected to total approximately £1.35 million, equating to an initial cash-on-cash yield of over 13 per cent.

 

In line with Duke's other investments and reflective of the participating nature of the Duke investment, the Distribution will be adjusted annually based on the percentage change in total combined gross revenues for the 12 months to 31 December 2019 compared with the prior financial year. The annual adjustment in the Distribution will be subject to an agreed collar.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless ICHC utilises an early buyback option (no buyback option available for the first four years).

 

Duke Royalty Portfolio

Following the completion of the ICHC Financing, the Company's portfolio of royalty investments is as follows with approximately GBP 42.5 million of capital deployed to date:

 

Royalty Partner    

Royalty Investment Amount

Date of Royalty Agreement

Temarca B.V       

Euro 9,000,000

April 2017

Lynx Equity (UK) Limited

GBP 9,000,000

October 2017

Trimite Global Coatings Limited

GBP 9,000,000

March 2018

Brownhills Investments Limited

GBP 6,500,000

April 2018

InterHealth Canada Holding Corp

GBP 10,000,000

August 2018

 

***ENDS***

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson/ Charlie Cannon-Brookes

 

+44 (0) 1481 741 240

Grant Thornton UK LLP 

(Nominated Adviser)

Colin Aaronson/ Samantha

Harrison

 

+44 (0) 20 7383 5100

 

Cenkos Securities plc 

(Joint Broker)

 

Julian Morse/ Michael Johnson

+44 (0) 207 397 8900

Mirabaud Securities Limited

(Joint Broker)

 

Peter Krens/ Edward Haig-Thomas

 

+44 (0) 20 3167 7222

Redleaf Communications

(PR)

 

Elisabeth Cowell/ Robin Tozer/ Ian Silvera

+44 (0) 20 3757 6880

[email protected]

 

 

About Duke Royalty

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

About InterHealth Canada

InterHealth Canada is a leading healthcare organization specializing in the development, commissioning and management of healthcare facilities. Our core business is to export Canada's Healthcare intellectual and management expertise to emerging economies. InterHealth Canada is committed to delivering internationally accredited healthcare management services with an emphasis on investment returns.

 

Our head office is located in Toronto, Canada with regional offices in Riyadh, London, Providenciales, Grand Turks, Warsaw and Dubai. We are committed to providing world's best practice, the latest knowledge and expertise through lifelong learning and delivering continuous professional development to our multidiscipline team.  Since 1994, InterHealth has employed over 5000 professionals worldwide and has provided healthcare to a combined population of over 20 million people.

 

For further information, please see the websites for the group: www.interhealthcanada.com

 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AGRSEDFIUFASELA

a d v e r t i s e m e n t